News
-
Vaccine definition changes
Thursday | Apr 9 2026A legislative amendment to the National Health Act 1953 has broadened the definition of 'vaccine' to include antibody-based immunising agents, such as nirsevimab (Beyfortus, Sanofi) for RSV, paving the way for inclusion on the National Immunisation Program (NIP).
-
Cannabis no help for mental health
Thursday | Apr 9 2026THE largest-ever review of the safety and efficacy of medicinal cannabis across a range of mental health conditions has found no evidence it is effective in treating anxiety, depression or post-traumatic stress disorder (PTSD).
-
Register now for Careers Summit
Thursday | Apr 9 2026REGISTRATION for the Pharmacy Careers Summit 2026 (PCS26) has now opened, with the free, virtual event taking place on Fri 10 Jul, 2026.
-
TGA takes next steps on Andrographis
Thursday | Apr 9 2026THE Therapeutic Goods Administration (TGA) has begun consultation on a proposal to remove Andrographis paniculata (Andrographis) from the list of permitted ingredients in listed medicines, following a concerning number of anaphylaxis cases (PD 21 Jan).
-
Nioxin launches Age Defense haircare products
Thursday | Apr 9 2026NIOXIN has released a new shampoo and conditioner in its Age Defense range, which is designed to rejuvenate the scalp, support hair follicles and maintain melanin production.
-
New look Essano launch
Thursday | Apr 9 2026AFFORDABLE New Zealand-based skincare brand Essano has undergone a brand transformation, reformulating and expanding its Hydration product range with a brand-new look.
-
Editor’s Choice: New postpartum product range is Due at Priceline
Thursday | Apr 9 2026POSTPARTUM recovery range Due has signed its first major pharmacy partnership through Priceline.
-
Revlon photo ready
Thursday | Apr 9 2026REVLON'S new PhotoReady Lifting Brow Gel (RRP $28) is a lightweight product that helps to sculpt, lift and set the brows, while also nourishing the hair, thanks to Provitamin B5 in the formulation.
-
FDA approves orforglipron
Thursday | Apr 9 2026THE US Food and Drug Administration (FDA) has approved oral weight-loss drug orforglipron (Foundayo, Eli Lilly) for adults with obesity, or overweight with weight-related medical problems.
-
TGA sunscreen review and webinar
Thursday | Apr 9 2026THE Therapeutic Goods Administration (TGA) has opened a public consultation looking into improvements to the regulation of sunscreens in Australia, and is inviting stakeholders to provide a response by 23 May 2026.
